|
|
Neutropenia
|
|
Neutropenia
[an error occurred while processing this directive]
Neupogen® Plus Antibiotics Decrease Febrile Neutropenia in Small ... Nov 8, 2005
...have reported that the addition of Neupogen (granulocyte-colony stimulating factor) to prophylactic antibiotics decreases febrile neutropenia in patients with ...
- Cancer Consultants (press release),
Addition of G-CSF Reduces Risk of Febrile Neutropenia in Small ... Nov 2, 2005
...of antibiotics and granulocyte colony-stimulating factor (G-CSF) is more effective than antibiotics alone at preventing febrile neutropenia during the first ...
- Cancer Consultants (press release),
Neulasta® and Aranesp® Provide Effective Hematopoietic Support ... Nov 21, 2005
...prophylactic administration of pegfilgrastim (Neulasta) and darbepoetin alfa (Aranesp) was effective and safe for prevention of febrile neutropenia and anemia ...
- Cancer Consultants (press release),
Cytokinetics Announces Clinical and Non-Clinical Results for ... Nov 17, 2005
The dose limiting toxicity in this combination regimen was prolonged (greater than or equal to 5 days) Grade 4 neutropenia. Other ...
- PharmaLive.com (press release),
ImmuneRegen to Respond to Dept. of Health and Human Services RFP ... Nov 22, 2005
...will remain focused on the procurement and stockpiling of up to 100,000 treatments of medical countermeasures to mitigate or treat Neutropenia associated with ...
- PR Newswire (press release),
New Treatment Combinations Expanding Options for Patients with ... Nov 17, 2005
While the novel combination was associated with lower incidence of the frequent chemotherapy adverse effects of neutropenia, nausea and vomiting, and diarrhea ...
- DG News
Treatment Advances in Colorectal Cancer Often Accompanied by ... Nov 17, 2005
Peripheral neuropathy and neutropenia are the primary toxicities of this drug, whether used in combination with 5-FU or other agents. ...
- DG News
Hollis-Eden Pharmaceuticals Releases Response to Department of ... Nov 1, 2005
30, 2005 by the Department of Health and Human Services (HHS) for "Acquisition Of Medical Countermeasures To Mitigate Or Treat Neutropenia Associated With ...
- Business Wire (press release),
Prophylactic G-CSF Reduces Infection-Related Mortality Nov 10, 2005
Research is focused on defining risk factors for the development of neutropenia among patients and developing risk stratification models for the use of ...
- Cancer Consultants (press release),
Journal of Clinical Oncology Publishes Pivotal Phase III Study ... Nov 1, 2005
The incidence of Grade 4 neutropenia was significantly lower for ABRAXANE compared with Taxol despite a 49% higher paclitaxel dose. ...
- Yahoo! News (press release)
Life-threatening Complications From Doxorubicin-Docetaxel ... Nov 3, 2005
...the groups combining doxorubicin with docetaxel (either alone or with cyclophosphamide) after interim analyses had shown rates of febrile neutropenia above 20 ...
- Journal of American Medical Association (subscription),
Novelos Therapeutics in Collaboration with Shriners Hospitals to ... Nov 8, 2005
NOV-002 treated animals did not experience severe neutropenia (loss of white blood cells used for fighting off infections) and demonstrated significantly ...
- Business Wire (press release),
Prophylactic G-CSFs May Reduce Infection-Related Mortality Nov 11, 2005
There is wide spread use of prophylactic Neupogen or Neulasta to shorten the period of neutropenia associated with intensive chemotherapy for the treatment of ...
- Cancer Consultants (press release),
Celgene Receives Approvable Letter From FDA for THALOMID(R) in ... Nov 15, 2005
...thrombosis. Decreased white blood cell counts, including neutropenia, have been reported in the clinical use of thalidomide. In ...
- PR Newswire (press release),
Pegasys(R) Shows Encouraging Interim Results for Hepatitis C ... Nov 11, 2005
...asthenia (65%), headache (43%), pyrexia (41%), myalgia (40%), irritability/anxiety/nervousness (33%), insomnia (30%), alopecia (28%), neutropenia (27%), nausea ...
- PR Newswire (press release),
Interim Phase 1 Data on RH1 Presented at AACR-NCI-EORTC Conference Nov 17, 2005
...m2. Clinically significant toxicities observed to date include neutropenia, thrombocytopenia and mild to moderate phlebitis. No ...
- PR Newswire (press release),
Seattle Genetics Initiates SGN-33 Clinical Trial Nov 17, 2005
...the production of normal blood cells, leading to a deficiency of red cells (anemia), platelets (thrombocytopenia) and normal white cells (neutropenia) in the ...
- Business Wire (press release),
Inimex Selected as One of Canada's Top 10 Life Science Investment ... Nov 8, 2005
...of an optimized proprietary compound, IMX942, for clinical development as a novel therapy for infections associated with fever and neutropenia in cancer ...
- Biotech Intelligence (press release),
Addition of Pixantrone to Rituxan Therapy Significantly Prolongs ... Nov 9, 2005
Side effects on pixantrone were generally mild (grade 1 or 2) with the exception of severe (grade 4) treatment-related neutropenia, which was seen in two ...
- PharmaLive.com (press release),
Novelos collaborating with Shriners Hospitals Nov 8, 2005
NOV-002-treated animals did not experience severe neutropenia (loss of white blood cells used for fighting off infections) and demonstrated significantly ...
- Boston Mass High Tech,
Roche and Protein Design Labs to Jointly Develop Daclizumab in ... Nov 1, 2005
...with cyclosporine and corticosteroids) were pain, fever, headache, asthenia, anemia, leucopenia (patients should be monitored for neutropenia; dosing should be ...
- PharmaLive.com (press release),
Hollis-Eden Announces Third Quarter 2005 Financial Results Nov 3, 2005
30, 2005 the Department of Health and Human Services (HHS) issued a draft Request for Proposal (RFP) for therapeutics to treat neutropenia associated with ARS. ...
- Genetic Engineering News,
Oral Chemotherapy Xeloda Shown to Extend Survival for Patients ... Nov 2, 2005
...events (equal to or greater than two percent) in the gemcitabine-capecitabine (GEM-CAP) combination arm of the study include neutropenia, increased white blood ...
- PR Newswire (press release),
Addition of Taxotere® to Standard Chemotherapy Improves Survival ... Nov 3, 2005
Serious adverse effects of treatment were also higher among patients receiving DCF. They included low while blood cell levels (neutropenia) and diarrhea. ...
- Cancer Consultants (press release),
Hepatitis Combination Therapy Okay for Children: Study Nov 15, 2005
All of the children experienced some side effects, but most were mild. Those included anemia, neutropenia, depression and suicidal thoughts. ...
- Hepatitis Neighborhood,
Life-threatening Complications From Doxorubicin-Docetaxel ... Nov 3, 2005
...sepsis associated with use of docetaxel plus doxorubicin as adjuvant chemotherapy, Dr Brain and colleagues 1 reported 3 cases of febrile neutropenia and severe ...
- Journal of American Medical Association (subscription),
Dose-Dense Chemotherapy Regimen for Non-Small Cell Lung Cancer Oct 25, 2005
...recovery. Inadequate bone marrow recovery may lead to low white blood cell levels (neutropenia) and an increased risk for infection. ...
- Cancer Consultants (press release),
Hana Biosciences Announces Positive Interim Results From a Phase I ... Nov 14, 2005
These interim results suggest: -- Talotrexin was well tolerated over multiple cycles of therapy, with mucositis, febrile neutropenia, and thrombocytopenia ...
- Business Wire (press release),
Cytokinetics Announces Clinical and Non-Clinical Data on Ispinesib ... Nov 10, 2005
KSP by Ispinesib, a Novel KSP Inhibitor Poster C203: Relationship Between the Antitumor Activity of Ispinesib, a Novel KSP inhibitor, and Neutropenia in a ...
- PR Newswire (press release),
Launch of New Drugs From Amgen, Ligand Pharmaceuticals ... Nov 2, 2005
...of Chemotherapy focuses on the five major side effects of chemotherapy treatment: thrombocytopenia, chemotherapy-induced anemia, neutropenia, oral mucositis ...
- PR Newswire (press release),
Oral Hycamtin® Better than Best Supportive Care for Recurrent ... Nov 14, 2005
Grades III/IV toxicities included hematologic toxicities (neutropenia, thrombocytopenia and anemia), nausea, vomiting and diarrhea in the Hycamtin arm. ...
- Cancer Consultants (press release),
Gemcitabine And Capecitabine Improved Overall Survival In Patients ... Nov 3, 2005
Toxicity effects recorded in both treatment groups included anaemia, neutropenia, thrombocytopenia, fever, diarrhoea and vomiting. ...
- Science Daily (press release)
Drug Combo Offers Hope to Pancreatic Cancer Patients Nov 2, 2005
Both treatment groups experienced “acceptable� levels of toxic side effects including anemia, neutropenia, thrombocytopenia, fever, diarrhea, and vomiting. ...
- Cancerpage.com,
Millennium Reports Strong Third Quarter 2005 Financial Results Oct 26, 2005
...percent of patients reported at least one episode of grade 4 toxicity; the most common grade 4 toxicities were thrombocytopenia (4%), neutropenia (2%), and ...
- Yahoo! News (press release)
ECCO: Xeloda-Gemzar Duo Extends Pancreatic Cancer Survival Nov 3, 2005
Grade 3 or 4 toxicities for the Gemzar-alone and Gemzar-Xeloda arms, respectively, were as follows: anemia (2%, 1%), neutropenia (11%, 17%), thrombocytopenia (2 ...
- MedPage Today,
Phase I Study of High Dose Weekly ABRAXANE Published in Journal of ... Nov 1, 2005
In the randomized metastatic breast cancer study, the most important adverse events included neutropenia (all cases 80%; severe 9%), anemia (all 33%; severe 1 ...
- PharmaLive.com (press release),
Combination chemo improves overall survival Nov 4, 2005
Side effects in both treatment groups included loss of red blood cells (anemia), loss of infection-fighting white blood cells (neutropenia), and loss of blood ...
- Cancerfacts.com,
Interferon with ribavirin is safe and effective for children with ... Nov 2, 2005
Severe side effects included anemia, neutropenia, depression and suicidal thoughts, and one child in the study attempted suicide. ...
- innovations report,
SU11248 Shows Activity in Tough-to-Treat Breast Cancer: Presented ... Oct 31, 2005
...hypertension (17%). Grade 3 hematologic toxicity included neutropenia (39%), anemia (2%), and thrombocytopenia (15%). Dr. Miller ...
- DG News
New Study Shows NOXAFIL(R) (Posaconazole) Oral Suspension ... Oct 25, 2005
...immunosuppressive therapy due to risk associated with donor compatibility and transplant complications that include prolonged neutropenia, graft failure and ...
- PR Newswire (press release),
Innovative Drug Tarceva Now Available in Europe to Tackle Growing ... Oct 30, 2005
...of malignancy), Kytril (for chemotherapy and radiotherapy-induced nausea and vomiting), Neupogen (for cancer-related neutropenia), and NeoRecormon (for anaemia ...
- PR Newswire UK (press release),
Full-Dose Chemo OK for Heavy Breast Cancer Patients Oct 27, 2005
But overweight and obese women were no more likely to require hospitalization for febrile neutropenia -- a serious side effect that happens when white blood ...
- ACS News Center,
Voriconazole - Effective for candidaemia with lesser side effects Nov 5, 2005
...included 370 patients who had at least one positive blood culture for Candida within 96 hours of entering the study, and who did not suffer from neutropenia. ...
- RxPG NEWS,
Tamiflu, Vistide and the Pentagon Agenda Nov 7, 2005
MD, Professor at the Department of Emergency Medicine, Medical College of Virginia, complications of Vistide include renal toxicity, neutropenia, fever, anemia ...
- PEJ News,
National Oncology Alliance Launches 'EDUCATE' Study Inviting ... Nov 1, 2005
..."National guidelines for the appropriate management of anemia and neutropenia have been available for many years, yet studies have not been able to confirm ...
- PharmaLive.com (press release),
Maxygen Reports Third Quarter 2005 Financial Results Oct 25, 2005
...development timeline; the timing of any INDs we might file; the ability of our next-generation G-CSF product to reduce the duration of neutropenia and the ...
- Yahoo! News (press release)
Cytogen Announces Presentation of Data from Phase II Study ... 03 Oct 2005
Following the first TAXSAM cycle of therapy, grade 3 or 4 neutropenia was seen in four patients at week three and six, respectively, after QUADRAMET ...
- PR Newswire (press release)
Hollis-Eden Comments on Issuance by the Department of Health and ... Sep 30, 2005
...announced that the Department of Health and Human Services (DHHS) has issued a Statement of Work (SOW) for therapeutics to treat neutropenia associated with ...
- Genetic Engineering News
Pegfilgrastim Significantly Reduces the Incidence of Febrile ... Sep 15, 2005
...protect patients with most types of cancer undergoing moderately myelosuppressive chemotherapy from infection, as manifested by febrile neutropenia (low white ...
- RxPG NEWS
Potential Marker of Chemotherapy Effectiveness in Lung Cancer ... Sep 6, 2005
According to a study published in The Lancet Oncology, development of neutropenia during chemotherapy for non-small cell lung cancer (NSCLC) may indicate ...
- Cancer Consultants (press release)
Prophylactic Antibacterial Prevents Infection in Cancer Patients Sep 9, 2005
One of the most common side effects of cancer treatment is low levels of immune cells, a condition called neutropenia. Neutropenia ...
- Cancer Consultants (press release)
Cytokinetics and GlaxoSmithKline Amend Collaboration Agreement for ... Sep 27, 2005
The dose-limiting toxicities observed to date are prolonged neutropenia, febrile neutropenia (with or without infection), elevated transaminases ...
- PharmaLive.com (press release)
Mysterious Fevers May Signal Lurking Cancer Sep 29, 2005
Cancer can cause fever through a variety of mechanisms, including occult infections, inflammation, vasculitis, and neutropenia, the researchers said. ...
- Mathaba.Net
Nektar Announces Inhaled Amphotericin B Product in Human Clinical ... Sep 29, 2005
...or chemotherapy for hematological malignancies, patients with certain genetic diseases, late stage AIDS with the associated neutropenia, and aplastic anemia ...
- PharmaLive.com (press release)
Judge returns after cancer treatment Sep 29, 2005
It wasn't until later that Lamb said he learned people with that condition, called neutropenia, have a 70 percent mortality rate.
- MLive.com
FDA Approvals: Remicade, Neulasta, NovoLog Sep 22, 2005
...of ulcerative colitis; pegfilgrastim injection for use in the first cycle of chemotherapy associated with a 17% or higher risk of neutropenia; and insulin ...
- Medscape (subscription)
FDA Expands Neulasta(R) Label; New Label Extends First-Cycle ... Sep 15, 2005
...patients withmost types of cancer undergoing moderately myelosuppressivechemotherapy from infection, as manifested by febrile neutropenia (lowwhite blood cell ...
- Finanzen.net
Levaquin® Prevents Bacterial Infection in Neutropenic Cancer ... Sep 9, 2005
England Journal of Medicine suggesting benefit from prophylactic Levaquin (levofloxacin) administration in patients with chemotherapy-induced neutropenia.[1],[2 ...
- Cancer Consultants (press release)
Toxicity predicts effective chemotherapy dose Sep 3, 2005
Dr Massimo Di Maio and colleagues hypothesised that neutropenia, a haematological toxicity, could be a predictor of drug activity and treatment efficacy. ...
- I-Newswire.com (press release)
Antibiotics Prevent Chemotherapy-Related Fever Sep 7, 2005
...at reducing the incidence of febrile episodes among patients with both solid tumors and hematologic cancers who experience chemotherapy-induced neutropenia. ...
- MedPage Today
Antibiotic Could Make Chemotherapy Safer Sep 7, 2005
When chemotherapy or radiation therapy reduces the numbers of neutrophils significantly, a condition called neutropenia develops. ...
- Forbes
Cellerant Therapeutics Adds $9 Million to Series B Round for a ... Sep 22, 2005
...well as CLT-001 for the treatment of autoimmune diseases and our cell-based product CLT-008 for the treatment of radiation- and chemotherapy-induced neutropenia ...
- Business Wire (press release)
Toxic Side Effect May Be Gauge of Chemotherapy Efficacy Aug 30, 2005
30-The presence of neutropenia appears to be a guide to oncologists as to whether chemotherapy is working, and it could help ensure that lung cancer patients ...
- MedPage Today
Levofloxacin Prevents Infection in Neutropenic Cancer Patients Sep 8, 2005
2005 (Reuters Health) - Fears of bacterial resistance have generally prevented the prophylactic use of fluoroquinolones in patients with cancer and neutropenia ...
- Cancerpage.com
FDA Safety Labeling Changes: Camptosar, Keppra, Prempro/Premphase Sep 21, 2005
In a prospective study of 66 irinotecan-treated patients, the mutation was associated with an increased risk of neutropenia and other drug-related toxicities ...
- Medscape (subscription)
Radioactive Monoclonal Antibody May Improve Survival After ... Sep 26, 2005
At over 5 years follow-up, more than half of the patients were still alive (51.3%). The major side effects were transient neutropenia and thrombocytopenia. ...
- Cancer Consultants (press release)
Advanced breast cancer, Taxotere more effective than Paclitaxel Sep 3, 2005
The use of G-CSF, a bone marrow growth factor that may be administered to reduce febrile neutropenia in patients receiving myelosuppressive chemotherapy, was ...
- Xagena.it
Fourth Phase III Study Shows Herceptin(R) Plus Chemotherapy ... Sep 13, 2005
In clinical trials, the incidence of moderate to severe neutropenia and of febrile neutropenia were higher in patients receiving Herceptin in combination with ...
- PR Newswire (press release)
Tarceva Approved in Europe for Lung Cancer Sep 20, 2005
...of malignancy), Kytril (for chemotherapy and radiotherapy-induced nausea and vomiting), Neupogen (for cancer-related neutropenia), and NeoRecormon (for anaemia ...
- PR Newswire UK (press release)
Chemotherapy Drug Update Sep 16, 2005
...infections. Almost half of the 1.3 million cancer patients in the US receiving chemotherapy are at risk of developing neutropenia. ...
- WTVY
Drug Helping Cancer Patients Getting Chemotherapy Sep 16, 2005
It's called Neulasta. A condition, called neutropenia, means a drop in white blood cells, those are your infection fighting cells. ...
- WNEP-TV
Calcitriol Can Be Safely Added to Chemotherapy for Prostate Cancer Sep 23, 2005
Such events included hypophosphatemia, neutropenia and, despite prophylactic use of anticoagulation, thromboembolic complications. ...
- Cancerpage.com
Celgene Revlimid Dose, Toxicity And Single-Arm Study Questions ... Sep 13, 2005
...in the clinical trial program. The most common events were neutropenia and thrombocytopenia (41.5% each). FDA noted that “of greater ...
- FDA Advisory Committee
Health Canada approves new targeted radioimmunotherapy Sep 8, 2005
Side Effects The most common adverse reactions occurring in the clinical trials included neutropenia, thrombocytopenia and anemia. ...
- Canada NewsWire (press release)
Celgene's Revlimid Phase II Data Sufficient For Full Approval In ... Sep 14, 2005
In the Celgene trial, 80% of patients required dose reductions due to toxicity consisting of largely neutropenia and thrombocytopenia. ...
- FDA Advisory Committee
Genmab Announces Positive Interim Results in Phase I/II HuMax(R) ... Sep 15, 2005
Investigators reported 5 serious adverse events assessed as potentially related to HuMax-CD20: hepatic cytolysis, herpes zoster, neutropenia (2 patients) and ...
- PR Newswire (press release)
Positive Results for Basilea's Novel Broad Spectrum Antifungal ... Sep 7, 2005
The expansion of the immunocompromised patient population including cancer patients with chemotherapy induced neutropenia, transplant recipients receiving ...
- PrimeZone (press release)
Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and ... Sep 7, 2005
...trial in patients who were receiving cyclic chemotherapy for solid tumors or lymphoma and who were at risk for temporary, severe neutropenia (fewer than 500 ...
- New England Journal of Medicine (subscription)
Antibiotics administered to cancer patients whose immune systems ... Sep 14, 2005
...on Chemo," September 9, 2005; Giampaolo Bucaneve et al, "Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia," New England ...
- National Center for Policy Analysis
Abelson-Taylor Hires Amie Casson Sep 15, 2005
She will handle the account for Neulasta (pegfilgrastim), an Amgen product that fights chemotherapy induced neutropenia (white blood cell deficiency) for ...
- PharmaLive.com (press release)
'Ecstatic' over boy's progress Sep 6, 2005
That's because Dennis no longer has neutropenia -- an abnormal decrease in the number of certain white blood cells in the blood. ...
- Ottawa Sun
Local outpouring for Katrina victims grows Sep 3, 2005
When she was 21 2, Taylor suffered from neutropenia -- the lack of white blood cells -- and spent long periods in Children's Floating Hospital in Boston ...
- Lowell Sun
ARV drugs prevent mother-child HIV31 Jul 2005
Such high concentrations may cause side effects such as anemia, neutropenia, and possible lead to the emergence of a drug-resistant virus. ...
- myDNA.com
Risk of Neutropenia Highest During the First Cycle of ChemotherapyJul 28, 2005
Researchers from the United States have reported that an initial episode of severe neutropenia or febrile neutropenia is most likely to occur during the first ...
- Cancer Consultants
Neutropenia Associated with Significant Decline in Quality of LifeJul 12, 2005
According to results recently presented at the 17th MASCC/ISOO International Symposium, patients who experience severe neutropenia suffer a significant decline ...
- Cancer Consultants
Sertraline- and Mirtazapine-Induced Severe NeutropeniaJun 30, 2005
To the Editor: Neutropenia is a rare and reversible side effect of antidepressant treatment (1–4). Six cases of agranulocytosis in approximately 2 million ...
- Am J Psychiatry (subscription)
Cytokinetics, Incorporated Reports Second Quarter 2005 Financial ...Jul 27, 2005
The dose-limiting toxicities observed to date are prolonged neutropenia, febrile neutropenia (with or without infection), elevated transaminases ...
- Business Wire
Meta-Analysis Reveals that Neulasta® Can Significantly Reduce the ...Jul 12, 2005
Neutropenia occurs when white blood cells (immune cells) are destroyed by chemotherapy, leaving the immune system unable to fight bacterial, viral and fungal ...
- Cancer Consultants
Further Evidence that Neulasta® Allows for Optimal Chemotherapy ...Jul 12, 2005
...symposium, data from a large meta-analysis provides further evidence that the use of Neulasta® (pegfilgrastim) to prevent neutropenia allows more patients to ...
- Cancer Consultants
Updated Meta-Analysis Shows Prophylactic G-CSFs Significantly ...Jul 7, 2005
...have reported that prophylactic recombinant human granulocyte colony-stimulating factors (G-CSFs) not only reduce the risk of febrile neutropenia across a wide ...
- Cancer Consultants
Significant Decline in Patient-Reported Quality of Life with the ...Jul 7, 2005
Researchers from the United States have reported results of a clinical trial that indicate patients who experience grade 3-4 neutropenia report greater symptom ...
- Cancer Consultants
Drug combo ups breast cancer survival-studyJul 15, 2005
Overall, the number and severity of side effects seen in both groups were similar, aside from a higher incidence of neutropenia in the combination group. ...
- Reuters
Epidemiology Study Reports New Information on Hypersensitivity ...Jul 26, 2005
Zidovudine, one component of TRIZIVIR, has been associated with hematologic toxicity including neutropenia and severe anemia, particularly in patients with ...
- Yahoo News
Maxygen Reports Second Quarter 2005 Financial ResultsJul 26, 2005
The Company is currently developing a novel G-CSF to treat neutropenia that may have significant advantages over the currently marketed G-CSF products. ...
- PharmaLive.com
Thoracic Cancer Patients Find New Hope with Alimta®Jul 10, 2005
Phase III trial, in previously treated, recurrent NSCLC(4). Patients treated with Alimta experienced considerably lower incidence of neutropenia (a drop in the ...
- Medical News Today
Hollis-Eden Announces FDA Clearance to Commence Human Clinical ...Jul 5, 2005
In October 2004, HHS issued a Request for Information (RFI) for therapeutics to treat neutropenia and thrombocytopenia associated with ARS. ...
- Business Wire
Genentech Updates Raptiva RisksJul 20, 2005
...necrotizing fasciitis (commonly known as flesh-eating bacteria), tuberculous pneumonia, bacterial sepsis, severe pneumonia with neutropenia, and worsening of ...
- TheStreet.com
Amgen Stock Could 'Cool Off' In Late 2005Jul 20, 2005
...modestly. In addition we believe the neutropenia franchise could get a lift from increased use in the primary prophylaxis setting.". ...
- Forbes
Major Response with Aranesp(R) in Anemic Patients with ...Jul 10, 2005
Sixteen percent (n=16) of patients experienced a serious adverse event, with anemia, neutropenia and chest pain as the most common. ...
- Medical News Today
Raptiva Label to Include Hemolytic Anemia WarningJul 20, 2005
...reports of necrotizing fasciitis, tuberculous pneumonia, bacterial sepsis with seeding of distant sites, severe pneumonia with neutropenia, and worsening of ...
- MedPage Today
Adding Trastuzumab to Docetaxel Improves Survival in Metastatic ...Jul 15, 2005
With the exception of a higher incidence of grade 3 to 4 neutropenia in the combination therapy group, the number and severity of adverse effects seen in each ...
- Medscape (subscription)
Celebrities stump for favorite causesJul 17, 2005
The Wall Street Journal reported that Rob Lowe received as much as $1 million from a pharmaceutical company to talk about febrile neutropenia, infections that ...
- San Jose Mercury News
Genzyme Launches Minimal Residual Disease Test for Common LeukemiaJul 19, 2005
Hematologic toxicities included pancytopenia/marrow hypoplasia (6%), anemia (80%), thrombocytopenia (72%), neutropenia (85%), and profound lymphopenia, and ...
- Yahoo News
COMUNICADO DE ROCHE PHARMACEUTICALS (1)Jul 13, 2005
...of malignancy), Kytril (for chemotherapy and radiotherapy-induced nausea and vomiting), Neupogen (for cancer-related neutropenia), and NeoRecormon (for anaemia ...
- Europa Press
Oral Hycamtin® and Platinol® Regimen Active in Small Cell Lung ...Jul 5, 2005
Overall, patients in the etoposide/Platinol group had more grade 4 neutropenia and grade 3/4 vomiting, while those receiving Hycamtin and Platinol had more ...
- Cancer Consultants
Amgen drug promising for bone marrow disorderJul 7, 2005
Sixteen percent of patients experienced serious side effects, including anemia, neutropenia, a decline in a type of white blood cell, and chest pain. ...
- Ventura County Star (subscription)
G-CSF Proposed as 'Ideal' Stroke DrugJul 7, 2005
...researchers said that G-CSF's ability to penetrate the blood-brain barrier and its documented history as a well-tolerated drug for treating neutropenia "make G ...
- MedPage Today
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Neutropenia
you may want to try searching the Internet using the Google search box below.
|
|
|
